Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross‐sectional study

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sanne‐Marije J. A. Hazen, Tania C. Sluckin, Karin Horsthuis, Doenja M. J. Lambregts, Regina G. H. Beets‐Tan, Roel Hompes, Tineke E. Buffart, Corrie A. M. Marijnen, Pieter J. Tanis, Miranda Kusters
Format: Artículo Open Access
Publié: Wiley 2024
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867017537144750080
author Sanne‐Marije J. A. Hazen
Tania C. Sluckin
Karin Horsthuis
Doenja M. J. Lambregts
Regina G. H. Beets‐Tan
Roel Hompes
Tineke E. Buffart
Corrie A. M. Marijnen
Pieter J. Tanis
Miranda Kusters
author_facet Sanne‐Marije J. A. Hazen
Tania C. Sluckin
Karin Horsthuis
Doenja M. J. Lambregts
Regina G. H. Beets‐Tan
Roel Hompes
Tineke E. Buffart
Corrie A. M. Marijnen
Pieter J. Tanis
Miranda Kusters
Sanne‐Marije J. A. Hazen
Tania C. Sluckin
Karin Horsthuis
Doenja M. J. Lambregts
Regina G. H. Beets‐Tan
Roel Hompes
Tineke E. Buffart
Corrie A. M. Marijnen
Pieter J. Tanis
Miranda Kusters
collection Wiley Open Access
contents Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross‐sectional study Sanne‐Marije J. A. Hazen Tania C. Sluckin Karin Horsthuis Doenja M. J. Lambregts Regina G. H. Beets‐Tan Roel Hompes Tineke E. Buffart Corrie A. M. Marijnen Pieter J. Tanis Miranda Kusters Colorectal Disease AbstractAimThis study aimed to determine the consequences of the new definition of rectal cancer for decision‐making in multidisciplinary team meetings (MDT). The new definition of rectal cancer, the lower border of the tumour is located below the sigmoid take‐off (STO), was implemented in the Dutch guideline in 2019 after an international Delphi consensus meeting to reduce interhospital variations.MethodAll patients with rectal cancer according to the local MDT, who underwent resection in 2016 in the Netherlands were eligible for this nationwide collaborative cross‐sectional study. MRI‐images were rereviewed, and the tumours were classified as above or on/below the STO.ResultsThis study registered 3107 of the eligible 3178 patients (98%), of which 2784 patients had an evaluable MRI. In 314 patients, the tumour was located above the STO (11%), with interhospital variation between 0% and 36%. Based on TN‐stage, 175 reclassified patients with colon cancer (6%) would have received different treatment (e.g., omitting neoadjuvant radiotherapy, candidate for adjuvant chemotherapy). Tumour location above the STO was independently associated with lower risk of 4‐year locoregional recurrence (HR 0.529; p = 0.030) and higher 4‐year overall survival (HR 0.732; p = 0.037) compared to location under the STO.ConclusionBy using the STO, 11% of the prior MDT‐based diagnosis of rectal cancer were redefined as sigmoid cancer, with potential implications for multimodality treatment and prognostic value. Given the substantial interhospital variation in proportion of redefined cancers, the use of the STO will contribute to standardisation and comparability of outcomes in both daily practice and trial settings. 10.1111/codi.17002 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/codi.17002
format Artículo Open Access
id wiley_oa_10_1111_codi_17002
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross‐sectional study
Sanne‐Marije J. A. Hazen
Tania C. Sluckin
Karin Horsthuis
Doenja M. J. Lambregts
Regina G. H. Beets‐Tan
Roel Hompes
Tineke E. Buffart
Corrie A. M. Marijnen
Pieter J. Tanis
Miranda Kusters
Colorectal Disease
Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross‐sectional study Sanne‐Marije J. A. Hazen Tania C. Sluckin Karin Horsthuis Doenja M. J. Lambregts Regina G. H. Beets‐Tan Roel Hompes Tineke E. Buffart Corrie A. M. Marijnen Pieter J. Tanis Miranda Kusters Colorectal Disease AbstractAimThis study aimed to determine the consequences of the new definition of rectal cancer for decision‐making in multidisciplinary team meetings (MDT). The new definition of rectal cancer, the lower border of the tumour is located below the sigmoid take‐off (STO), was implemented in the Dutch guideline in 2019 after an international Delphi consensus meeting to reduce interhospital variations.MethodAll patients with rectal cancer according to the local MDT, who underwent resection in 2016 in the Netherlands were eligible for this nationwide collaborative cross‐sectional study. MRI‐images were rereviewed, and the tumours were classified as above or on/below the STO.ResultsThis study registered 3107 of the eligible 3178 patients (98%), of which 2784 patients had an evaluable MRI. In 314 patients, the tumour was located above the STO (11%), with interhospital variation between 0% and 36%. Based on TN‐stage, 175 reclassified patients with colon cancer (6%) would have received different treatment (e.g., omitting neoadjuvant radiotherapy, candidate for adjuvant chemotherapy). Tumour location above the STO was independently associated with lower risk of 4‐year locoregional recurrence (HR 0.529; p = 0.030) and higher 4‐year overall survival (HR 0.732; p = 0.037) compared to location under the STO.ConclusionBy using the STO, 11% of the prior MDT‐based diagnosis of rectal cancer were redefined as sigmoid cancer, with potential implications for multimodality treatment and prognostic value. Given the substantial interhospital variation in proportion of redefined cancers, the use of the STO will contribute to standardisation and comparability of outcomes in both daily practice and trial settings. 10.1111/codi.17002 http://creativecommons.org/licenses/by/4.0/
title Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross‐sectional study
topic Colorectal Disease
url https://onlinelibrary.wiley.com/doi/10.1111/codi.17002